Asian Paints

2785.7 -5.20

Cipla

1496.9 -2.70

Eicher Motors

7134.5 73.00

Nestle India

1234.6 -6.00

Grasim Inds

2806.6 7.50

Hindalco Inds.

848.8 11.65

Hind. Unilever

2275.6 -5.50

ITC

399.8 -1.90

Trent

4045.2 -63.50

Larsen & Toubro

4062.4 -1.40

M & M

3612.8 -8.20

Reliance Industr

1544.4 2.10

Tata Consumer

1179.8 9.90

Tata Motors PVeh

346.35 0.90

Tata Steel

170.34 0.51

Wipro

261.14 1.92

Apollo Hospitals

6921.5 -130.00

Dr Reddy's Labs

1272 -4.90

Titan Company

3907.9 -21.60

SBI

975.85 14.70

Shriram Finance

864.2 15.80

Bharat Electron

385.6 -2.40

Kotak Mah. Bank

2173.2 -9.20

Infosys

1602 9.10

Bajaj Finance

999.6 1.20

Adani Enterp.

2232.5 -15.40

Sun Pharma.Inds.

1792.9 11.60

JSW Steel

1079.3 -3.30

HDFC Bank

984 -10.30

TCS

3217.8 12.70

ICICI Bank

1352.4 -13.60

Power Grid Corpn

261.1 0.75

Maruti Suzuki

16398 44.00

Axis Bank

1224.7 5.10

HCL Technologies

1655 3.30

O N G C

232.91 0.70

NTPC

321.25 0.25

Coal India

384.75 3.15

Bharti Airtel

2108 6.00

Tech Mahindra

1579.4 1.20

Jio Financial

293.15 -2.10

Adani Ports

1486.3 -12.70

HDFC Life Insur.

753.5 -10.85

SBI Life Insuran

2010.2 -25.80

Max Healthcare

1031.1 -41.90

UltraTech Cem.

11540 12.00

Bajaj Auto

8895 -113.00

Bajaj Finserv

2021.2 -14.00

Interglobe Aviat

4980.5 6.50

Eternal

284.45 0.00

IPO-Synopsis
Nephrocare Health Services Ltd
  • Registered Office: 5th Flr D Block iLabs Centre,Plot 18 Software Units Sy.#.64, Hyderabad - 500081, Telangana, India. Phone : +91 40 4240 8039   Fax:
  • Email : cs@nephroplus.com
  • Website :www.nephroplus.com
Initial public offering of 18,943,020 equity shares of face value of Rs.2/- each ("equity shares") of Nephrocare Health Services Limited ("the company" or the "company" or the "issuer") for cash at a price of Rs.460/- per equity share face value of Rs.2/- (including a securities premium of Rs.458/- per equity share) ("offer price") aggregating to Rs.871.05 crores ("offer") comprising a fresh issue of 7,690,162 equity shares of face value of Rs.2/- each aggregating to Rs.353.41 crores ("fresh issue") and an offer for sale of 11,253,102 equity shares of face value of Rs.2/- each ("offered shares") aggregating to Rs.517.64 crores , comprising an offer for sale of 1,521,728 equity shares of face value of Rs.2/- each aggregating to Rs.70.00 crores by Investcorp Private Equity Fund II and 1,604,907 equity shares of face value of Rs.2/- each aggregating to Rs.73.83 crores by Healthcare Parent Limited and 147,765 equity shares of face value of Rs.2/- each aggregating to Rs.6.80 crores by Investcorp Growth Opportunity Fund and 2,888,911 equity shares of face value of Rs.2/- each aggregating to Rs.132.89 crores by Edoras Investment Holdings Pte. Ltd. ("promoter selling shareholders") and 121,985 equity shares of face value of Rs.2/- each aggregating to Rs.5.61 crores by Investcorp India Private Equity Opportunity Limited and 3,089,663 equity shares of face value of Rs.2/- each aggregating to Rs.142.12 crores by International Finance Coproration and 1,433,468 equity shares of face value of Rs.2/- each aggregating to Rs.65.94 crores by 360 One Special Opportunities Fund - Series 9 and 444,675 equity shares of face value of Rs.2/- each aggregating to Rs.20.46 crores by 360 One Special Opportunities Fund - Series 10 ("other selling shareholders" and together with the promoter selling shareholders, the "selling shareholders" and such offer for sale by the selling shareholders, the "offer for sale"). The offer constituted 18.88% of the post-offer paid-up equity share capital of the company.
Issue
Opens On Closes On
10-Dec-25 12-Dec-25
Money Payable On
Application Allotment
460.00 0.00
Minimum Application for shares in Nos : 32 Further Multiples of : 32
Cr Lead Managers to the Issue
Project Cost (.Cr) 325.15 Ambit Private Limited
Project Financed through Current Offer (.Cr) 871.05  
Post Issue Equity Share Capital (.Cr) 20.07
Issue Price () 460.00
Projects
Capital expenditure by our Company for opening new dialysis clinics in India
Pre-payment, or scheduled repayment, in full or part, of certain borrowings availed by our Company
General corporate purposes
Promoted By
Vikram Vuppala
Bessemer Venture Partners Trus
Edoras Investment Holdings Pte
Listing At
BSE
NSE
Registrar to the Issue
No Data Available

DJIA 48129.39
-308.18 -0.64%
S&P 500 6819.35
-18.16 -0.27%
HANG SENG 25468.79
233.37 0.92%
NIKKEI 225 49518.65
135.36 0.27%
FTSE 100 9795.97
111.18 1.15%
NIFTY 25818.55
-41.55 -0.16%
×
Ask Your Question
close
refresh